The Stem Cell Technologies and Applications Market Report 2022-2032: This report will prove invaluable to leading firms striving for the new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rise in Stem Cell Clinical Trials
Recent years have seen a significant expansion in both stem cell research and the clinical use of these promising cells. The National Institute for Health (NIH) database reported a total of 374 registered clinical trials of which unknown status were not considered. It shows that there has been 3 times expansion in the total number of clinical trials conducted since 2011.Clinical experiments using stem cells have changed the course of the developing field in recent years. While many teams continue to develop and broaden the role of bone marrow and cord blood stem cells for their cutting-edge applications in immune and blood disorders, many others are seeking to expand the applications of the various stem cell types found in bone marrow and cord blood, particularly mesenchymal stem cells, to uses beyond those that could be resolved by replacing cells in their own lineage. Other adult stem cell types, particularly brain stem cells, are being used more frequently by research teams to treat disorders where either in-lineage cell replacement or extracellular factors may have a positive impact. The majority of MSC trials are with allogenic cells and these trials are being conducted globally with largest activity witnessed in U.S., Europe and China. However, despite increase in clinical trials and significant investments being made for conducting these trials the commercialization of these trials have been slow and is a matter of concern for all the shareholders of this industry
What Questions Should You Ask before Buying a Market Research Report?
• How is the stem cell technologies and applications market evolving?
• What is driving and restraining the stem cell technologies and applications market?
• How will each stem cell technologies and applications submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each stem cell technologies and applications submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading stem cell technologies and applications markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the stem cell technologies and applications projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of stem cell technologies and applications projects taking place now and over the next 10 years?
• Is there a greater need for product commercialization to further scale the stem cell technologies and applications market?
• Where are the stem cell technologies and applications market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the stem cell technologies and applications market today, and over the next 10 years:
• Our 355-page report provides 170 tables and 221 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the stem cell technologies and applications market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising stem cell technologies and applications prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Market Segment by Type
• Allogeneic Stem Cell Therapy
• Autologous Stem Cell Therapy
Market Segment by Cell Source
• Adipose tissue-derived MSCs
• Bone marrow-derived MSCs
• Placental/umbilical cord-derived MSCs
Market Segment by Product
• Adult Stem Cells
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells
Market Segment by Technology
• Cell Acquisition
• Cell Production
• Cryopreservation
• Expansion & Sub-Culture
• Other Technology
Market Segment by Application
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Inflammatory & Autoimmune Diseases
• Musculoskeletal Disorders
• Other Applications
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• Turkey
• South Africa
• UAE
• Rest of the Middle East & Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Stem Cell Technologies and Applications Market, 2022 to 2032, with a focus on this segment of companies’ operations.
Leading companies and the potential for market growth
• Athersys, Inc.
• Biorestorative Therapies, Inc.
• BrainStorm Cell Limited
• Cellaïon SA
• Cellular Biomedicine Group, Inc.
• Cynata Therapeutics Limited
• Gamida Cell Ltd.
• Kangstem Biotech Co., Ltd.
• Mesoblast Limited
• Pluristem Therapeutics Inc.
• Plus Therapeutics, Inc.
• Sangamo Therapeutics, Inc.
• StemCell Technologies Inc.
• Vericel Corporation
• ViaCyte, Inc.
Overall world revenue for Stem Cell Technologies and Applications Market, 2022 to 2032 in terms of value the market will surpass US$9,922 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Stem Cell Technologies and Applications Market, 2022 to 2032 report help you?
In summary, our 350+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Stem Cell Technologies and Applications Market, 2022 to 2032 Market, with forecasts for type, cell source, product, technology, application, and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Stem Cell Technologies and Applications Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Stem Cell Technologies and Applications Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Stem Cell Technologies and Applications Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Stem Cell Technologies and Applications Market Report 2022-2032: Forecasts by Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), by Cell Source (Adipose Tissue-derived MSCs, Bone Marrow-derived MSCs, Placental/Umbilical Cord-derived MSCs), by Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-Culture, Other), by Application (Cancer, Cardiovascular Diseases, Neurological Disorders, Inflammatory & Autoimmune Diseases, Musculoskeletal Disorders, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Stem Cell Technologies and Applications Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
2.1 Geographical Snapshot: Global Stem Cell Technologies and Applications Market
2.2 Type Segment: Market Attractiveness Index
2.3 Cell Source Segment: Market Attractiveness Index
2.4 Product Segment: Market Attractiveness Index
2.5 Technology Segment: Market Attractiveness Index
2.6 Application Segment: Market Attractiveness Index
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.2 Market Restraining Factors
3.2.3 Market Opportunities
3.3 Supply Chain
3.4 Value Chain
3.5 COVID-19 Impact Analysis
3.5.1 Risks of COVID-19 for those Undergoing Stem Cell Transplants
3.6 Porter’s Five Forces Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Competitive Rivalry
3.6.4 Threat from Substitutes
3.6.5 Threat of New Entrants
3.7 PESTLE Analysis
3.7.1 Political Factors
3.7.2 Economic Factors
3.7.3 Social Factors
3.7.4 Technological Factors
4 Global Stem Cell Technologies and Applications Market Analysis by Type
4.1 Key Findings
4.2 Type Segment Growth Prospects
4.3 Type Segment: Market Attractiveness Index
4.4 Global Stem Cell Technologies and Applications Market Share by Type, 2022 & 2032
4.5 Global Stem Cell Technologies and Applications Market by Type
4.6 Allogenic Segment Market
4.6.1 Growing Prevalence of Cancer and Cardiovascular Diseases
4.6.2 Global Allogeneic Stem Cell Therapy Market by Type
4.6.3 Global Allogeneic Stem Cell Therapy Market by Region
4.7 Autologous Segment Market
4.7.1 Rising Frequency of Cancer
4.7.2 Global Autologous Stem Cell Therapy Market Forecast
4.7.3 Global Autologous Stem Cell Therapy Market by Region
5 Global Stem Cell Technologies and Applications Market Analysis by Cell Source
5.1 Key Findings
5.2 Cell Source Segment Growth Prospects
5.3 Cell Source Segment: Market Attractiveness Index
5.4 Global Stem Cell Technologies and Applications Market Share by Cell Source, 2022 & 2032
5.5 Global Stem Cell Technologies & Applications Market by Cell Source
5.6 Adipose Tissue- derived MSCs Segment Market Forecast
5.6.1 Source and Implication
5.6.2 Clinical Applications for Tissue Repair
5.6.3 Global Adipose Tissue-Derived MSCs Market Forecast
5.6.4 Global Adipose tissue-derived MSCs Market by Region
5.7 Bone Marrow- derived MSCs Segment Market Forecast
5.7.1 Bone Marrow Concept
5.7.2 Emerging Technology
5.7.3 Global Bone marrow-derived MSCs Market Forecast
5.7.4 Global Bone Marrow-Derived MSCs Market by Region
5.8 Placental/ Umbilical Cord- Derived MSCs Segment Market Forecast
5.8.1 Placental/ Umbilical Cord- Derived MSCs
5.8.2 Therapeutic Potential
5.8.3 Global Placental/Umbilical Cord-Derived MSCs Market Forecast
5.8.4 Global Placental/Umbilical Cord-Derived MSCs Market by Region
6 Global Stem Cell Technologies and Applications Market Analysis by Product
6.1 Key Findings
6.2 Product Segment Growth Prospects
6.3 Product Segment: Market Attractiveness Index
6.4 Global Stem Cell Technologies and Applications Market Share by Product, 2022 & 2032
6.5 Global Stem Cell Technologies & Applications Market by Product
6.6 Adult Stem Cells Segment Market Forecast
6.6.1 Rising Application Areas
6.6.2 Global Adult Stem Cells Market Forecast
6.6.3 Global Adult Stem Cells Market by Region
6.7 Human Embryonic Stem Cells Segment Market Forecast, 2021-2031
6.7.1 Increasing Research and Development Activities
6.7.2 Global Human Embryonic Stem Cells Market Forecast
6.7.3 Global Human Embryonic Stem Cells Market by Region
6.8 Induced Pluripotent Stem Cells Segment Market Forecast, 2021-2031
6.8.1 Favourable Government Support
6.8.2 Global Induced Pluripotent Stem Cells Market Forecast
6.8.3 Global Induced Pluripotent Stem Cells Market by Region
6.9 Very Small Embryonic Like Stem Cells
6.9.1 Global Very Small Embryonic Like Stem Cells Market Forecast
6.9.2 Global Very Small Embryonic Like Stem Cells Market by Region
7 Global Stem Cell Technologies and Applications Market Analysis by Technology
7.1 Key Findings
7.2 Technology Segment Growth Prospects
7.3 Technology Segment: Market Attractiveness Index
7.4 Global Stem Cell Technologies and Applications Market Share by Technology, 2022 & 2032
7.5 Global Stem Cell Technologies & Applications Market by Technology
7.6 Cell Acquisition Segment Market Forecast
7.6.1 Global Cell Acquisition Market Forecast
7.6.2 Global Cell Acquisition Market by Region
7.7 Cell Production Segment Market Forecast
7.7.1 Increasing Research and Development by Companies for the Development of Stem Cell Products
7.7.2 Global Cell Production Market Forecast
7.7.3 Global Cell Production Market by Region
7.8 Cryopreservation Segment Market Forecast
7.8.1 Surge in Research and Medical Applications
7.8.2 Global Cryopreservation Market Forecast
7.8.3 Global Cryopreservation Market by Region
7.9 Expansion & Sub-Culture Segment Market Forecast
7.9.1 Sub-culture
7.9.2 Rising Incidence of Chronic Diseases
7.9.3 Global Expansion & Sub-Culture Market Forecast
7.9.4 Global Expansion & Sub-Culture Market Forecast by Region
7.10 Other Technology Market Forecast
7.10.1 Global Other Technology Market Forecast
7.10.2 Global Other Technology Market by Region
8 Global Stem Cell Technologies and Applications Market Analysis by Application
8.1 Key Findings
8.2 Application Segment Growth Prospects
8.3 Application Segment: Market Attractiveness Index
8.4 Global Stem Cell Technologies and Applications Market Share by Application, 2022 & 2032
8.4.1 Global Stem Cell Technologies & Applications Market by Application
8.5 Therapeutic Application Segment Market Forecast
8.5.1 Rising Prevalence of Cardiovascular Diseases
8.5.2 Utilizing Stem Cell Technologies Therapeutically to Treat Parkinson's Illness
8.5.1 Cancer Segment Market Forecast
8.5.2 Cardiovascular Segment Market Forecast
8.5.3 CNS Segment Market Forecast
8.5.4 Inflammatory & Autoimmune Diseases Segment Market Forecast
8.5.5 Musculoskeletal Disorders Segment Market Forecast
8.6 Non-Therapeutic Application Segment Market Forecast
8.6.1 Rising Awareness of Stem Cell therapies propels the Growth of Stem Cell Banking
8.6.2 Global Other Applications Market Forecast
8.6.3 Global Other Applications Market by Region
9 Global Stem Cell Technologies and Applications Market Analysis by Region
9.1 Key Findings
9.2 Overview
9.3 Global Stem Cell Technologies & Applications, By Region Market Attractiveness Index
9.4 Global Stem Cell Technologies and Applications Market Share by Application, 2022 & 2032
9.5 Global Stem Cell Technologies & Applications Market Forecast
9.5.1 Global Stem Cell Technologies & Applications Market Forecast
9.5.2 Global Stem Cell Technologies & Applications Market Forecast (Post-CoViD-19)
9.6 Global Stem Cell Technologies & Applications Market by Region
9.6.1 Global Stem Cell Technologies & Applications Market by Region Forecast
9.6.2 Global Stem Cell Technologies & Applications Market by Region Forecast (Post-CoViD-19)
10 North America Stem Cell Technologies and Applications Market Analysis
10.1 Key Findings
10.2 North America Stem Cell Technologies and Applications Market Attractiveness Index
10.3 Rising Prevalence of Cancer
10.4 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast
10.5 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
10.6 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
10.7 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
10.8 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
10.9 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
10.10 North America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
10.11 U.S. Stem Cell Technologies & Application Market Forecast
10.11.1 Growing Biotechnology Sector and Increasing Stem Cell Research
10.12 Canada Stem Cell Technologies & Application Market Forecast
10.12.1 Growing Biotechnology Sector and Increasing Stem Cell Research
11 Europe Stem Cell Technologies and Applications Market Analysis
11.1 Key Findings
11.2 Europe Stem Cell Technologies and Applications Market Attractiveness Index
11.3 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
11.4 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
11.5 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
11.6 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
11.7 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
11.8 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
11.9 Europe Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
11.10 Germany Stem Cell Technologies & Application Market Forecast
11.10.1 Rising Technological Advancements Supports the Growth of the Market
11.11 U.K. Stem Cell Technologies & Application Market Forecast
11.11.1 Increasing Research and Development Activities
11.12 France Stem Cell Technologies & Application Market Forecast, 2021-2031
11.12.1 Introduction of New and Innovative Stem Cell Products for Rare Diseases
11.13 Italy Stem Cell Technologies & Application Market Forecast
11.13.1 Increasing Clinical Trials
11.14 Spain Stem Cell Technologies & Application Market Forecast
11.14.1 Rising Research and Development Activities
11.15 Rest of Europe Stem Cell Technologies & Application Market Forecast, 2021-2031
11.15.1 Rising Need for New and Innovative Technologies
11.15.2 Russia Stem Cell Technologies & Application Market Forecast
12 Asia-Pacific Stem Cell Technologies and Applications Market Analysis
12.1 Key Findings
12.2 Asia-Pacific Stem Cell Technologies and Applications Market Attractiveness Index
12.3 Rise in Aging Population
12.4 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
12.5 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
12.6 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
12.7 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
12.8 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
12.9 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
12.10 Asia-Pacific Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
12.11 Japan Stem Cell Technologies & Application Market Forecast
12.11.1 Favourable Government Policies
12.12 China Stem Cell Technologies & Application Market Forecast
12.12.1 Perspective of China for Cell and Gene Therapies (CGT)
12.13 India Stem Cell Technologies & Application Market Forecast
12.13.1 Increasing Research and Development Activities
12.14 South Korea Stem Cell Technologies & Application Market Forecast
12.14.1 HK inno.N (South Korea) and GC Cell (South Kores) Signed a Joint Research and Development Contract for Creating New Cell Therapies
12.15 Australia Stem Cell Technologies & Application Market Forecast
12.15.1 Rising Number of Companies Entering Stem Cell Technologies and Application Market
12.16 Rest of Asia-Pacific Stem Cell Technologies & Application Market Forecast
12.16.1 Favourable Government Support
13 Latin America Stem Cell Technologies and Applications Market Analysis
13.1 Key Findings
13.2 Latin America Stem Cell Technologies and Applications Market Attractiveness Index
13.3 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
13.4 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
13.5 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
13.6 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
13.7 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
13.8 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
13.9 Latin America Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
13.10 Brazil Stem Cell Technologies & Application Market Forecast
13.11 Mexico Stem Cell Technologies & Application Market Forecast
13.12 Rest of LATAM Stem Cell Technologies & Application Market Forecast
14 Middle-East & Africa Stem Cell Technologies and Applications Market Analysis
14.1 Key Findings
14.2 Middle East & Africa Stem Cell Technologies and Applications Market Attractiveness Index
14.3 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Value
14.4 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Country
14.5 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Type
14.6 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Cell Source
14.7 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Product
14.8 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Technology
14.9 Middle East & Africa Stem Cell Technologies and Applications Market Size Estimation and Forecast by Application
14.10 UAE Stem Cell Technologies & Application Market Forecast
14.11 South Africa Stem Cell Technologies & Application Market Forecast
14.12 Turkey Stem Cell Technologies & Application Market Forecast
14.13 Rest of MEA Stem Cell Technologies & Application Market Forecast
15 Competitive Landscape
15.1 Company Share Analysis
15.2 Key Business Strategy Analysis- Acquisition
15.3 Key Business Strategy Analysis- Agreement
15.4 Key Business Strategy Analysis- Approval
15.5 Key Business Strategy Analysis- Collaboration
15.6 Key Business Strategy Analysis- Contract
15.7 Key Business Strategy Analysis- Expansion
15.8 Key Business Strategy Analysis- Investment
15.9 Key Business Strategy Analysis- Joint Venture
15.10 Key Business Strategy Analysis- Merger
15.11 Key Business Strategy Analysis- New Product Launch
15.12 Key Business Strategy Analysis- Partnership
16 Company Profiles
16.1 Pipeline Analysis
16.1 Athersys, Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Financial Analysis
16.1.4 Product Benchmarking
16.1.5 Strategic Outlook
16.2 Mesoblast Limited
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Financial Analysis
16.2.4 Product Benchmarking
16.2.5 Strategic Outlook
16.3 Cellular Biomedicine Group, Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.4 Product Benchmarking
16.3.5 Strategic Outlook
16.4 Cynata Therapeutics Limited
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Financial Analysis
16.4.4 Product Benchmarking
16.4.5 Strategic Outlook
16.5 Plus Therapeutics, Inc.
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.4 Product Benchmarking
16.5.5 Strategic Outlook
16.6 Biorestorative Therapies, Inc.
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Financial Analysis
16.6.4 Product Benchmarking
16.6.5 Strategic Outlook
16.7 Pluristem Therapeutics Inc.
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.4 Product Benchmarking
16.7.5 Strategic Outlook
16.8 Cellaïon SA
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Financial Analysis
16.8.4 Product Benchmarking
16.8.5 Strategic Outlook
16.9 Sangamo Therapeutics, Inc.
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Financial Analysis
16.9.4 Product Benchmarking
16.9.5 Strategic Outlook
16.10 StemCell Technologies Inc.
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Financial Analysis
16.10.4 Product Benchmarking
16.10.5 Strategic Outlook
16.11 Vericel Corporation
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.4 Product Benchmarking
16.11.5 Strategic Outlook
16.12 BrainStorm Cell Limited.
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Financial Analysis
16.12.4 Product Benchmarking
16.12.5 Strategic Outlook
16.13 Gamida Cell Ltd.
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.4 Product Benchmarking
16.13.5 Strategic Outlook
16.14 ViaCyte, Inc.
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Financial Analysis
16.14.4 Product Benchmarking
16.14.5 Strategic Outlook
16.15 Kangstem Biotech Co., Ltd.
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.4 Product Benchmarking
16.15.5 Strategic Outlook
17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players
List of Tables
Table 1 Global Stem Cell Technologies and Applications Market Snapshot, 2022 & 2032 (US$Million, CAGR %)
Table 2 Global Stem Cell Banks and Region
Table 3 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 4 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 5 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 6 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 7 Global Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 8 Global Allogeneic Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 9 Global Allogeneic Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 10 Global Autologous Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 11 Global Autologous Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 12 Global Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 13 Global Adipose tissue-derived MSCs Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 14 Global Adipose tissue-derived MSCs Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 15 Global Bone marrow-derived MSCs Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 16 Global Bone marrow-derived MSCs Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 17 Global Placental/umbilical cord-derived MSCs Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 18 Global Placental/umbilical cord-derived MSCs Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 19 Global Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 20 Global Adult Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 21 Global Adult Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 22 Global Human Embryonic Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 23 Global Human Embryonic Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 24 Global Induced Pluripotent Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 25 Global Induced Pluripotent Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 26 Global Very Small Embryonic Like Stem Cells Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 27 Global Very Small Embryonic Like Stem Cells Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 28 Global Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 29 Global Cell Acquisition Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 30 Global Cell Acquisition Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 31 Global Cell Production Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 32 Global Cell Production Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 33 Global Cryopreservation Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 34 Global Cryopreservation Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 35 Global Expansion & Sub-Culture Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 36 Global Expansion & Sub-Culture Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 37 Global Other Technology Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 38 Global Other Technology Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 39 Global Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 40 Global Cancer Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 41 Global Cancer Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 42 Global Cardiovascular Diseases Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 43 Global Cardiovascular Diseases Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 44 Global Neurological Disorders Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 45 Global Neurological Disorders Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 46 Global Inflammatory & Autoimmune Diseases Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 47 Global Inflammatory & Autoimmune Diseases Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 48 Global Musculoskeletal Disorders Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 49 Global Musculoskeletal Disorders Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 50 Global Other Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 51 Global Other Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 52 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 53 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 54 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 55 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 56 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 57 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 58 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 59 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 60 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 61 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 62 North America Stem Cell Technologies & Applications Market, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 63 North America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 64 North America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 65 North America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 66 North America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 67 North America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 68 North America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 69 US Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 70 Canada Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 71 Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 72 Europe Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 73 Europe Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 74 Europe Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 75 Europe Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 76 Europe Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 77 Europe Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 78 Germany Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 79 UK Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 80 France Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 81 Italy Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 82 Spain Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 83 Rest of Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 84 Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 85 Asia-Pacific Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 86 Asia-Pacific Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 87 Asia-Pacific Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 88 Asia-Pacific Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 89 Asia-Pacific Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 90 Asia-Pacific Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 91 Japan Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 92 China Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 93 India Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 94 South Korea Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 95 Australia Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 96 Rest of Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 97 Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 98 Latin America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 99 Latin America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 100 Latin America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 101 Latin America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 102 Latin America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 103 Latin America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 104 Brazil Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 105 Mexico Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 106 Rest of Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 107 Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 108 Middle East & Africa Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 109 Middle East & Africa Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 110 Middle East & Africa Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 111 Middle East & Africa Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 112 Middle East & Africa Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 113 Middle East & Africa Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 114 UAE Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 115 South Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 116 Turkey Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 117 Rest of Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Table 118 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 119 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 120 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 121 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 122 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 123 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 124 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 125 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 126 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 127 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 128 Key Business Strategies Adopted by Key Players in Global Stem Cell Technologies and Applications Market
Table 129 Athersys, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Athersys, Inc.: Product Benchmarking
Table 131 Athersys, Inc.: Strategic Outlook
Table 132 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Bristol-Myers Squibb Company: Product Benchmarking
Table 134 Cellular Biomedicine Group, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 Cellular Biomedicine Group, Inc. : Product Benchmarking
Table 136 Cellular Biomedicine Group, Inc. : Strategic Outlook
Table 137 Cynata Therapeutics Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Cynata Therapeutics Limited: Product Benchmarking
Table 139 Cynata Therapeutics Limited: Strategic Outlook
Table 140 Plus Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 141 Plus Therapeutics, Inc.: Product Benchmarking
Table 142 Plus Therapeutics, Inc.: Strategic Outlook
Table 143 BioRestorative Therapies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 144 BioRestorative Therapies, Inc.: Product Benchmarking
Table 145 BioRestorative Therapies, Inc.: Strategic Outlook
Table 146 Pluristem Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 147 Pluristem Therapeutics Inc.: Product Benchmarking
Table 148 Pluristem Therapeutics Inc.: Strategic Outlook
Table 149 Cellaïon SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 150 Cellaïon SA: Product Benchmarking
Table 151 Sangamo Therapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 152 Sangamo Therapeutics, Inc.: Product Benchmarking
Table 153 Sangamo Therapeutics, Inc.: Strategic Outlook
Table 154 StemCell Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 155 StemCell Technologies Inc.: Product Benchmarking
Table 156 StemCell Technologies Inc.: Strategic Outlook
Table 157 Vericel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 158 Vericel Corporation: Product Benchmarking
Table 159 Vericel Corporation: Strategic Outlook
Table 160 BrainStorm Cell Limited. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 161 BrainStorm Cell Limited. : Product Benchmarking
Table 162 BrainStorm Cell Limited. : Strategic Outlook
Table 163 Gamida Cell Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 164 Gamida Cell Ltd.: Product Benchmarking
Table 165 Gamida Cell Ltd.: Strategic Outlook
Table 166 ViaCyte, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 167 ViaCyte, Inc.: Product Benchmarking
Table 168 Kangstem Biotech Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Kangstem Biotech Co., Ltd.: Product Benchmarking
Table 170 Kangstem Biotech Co., Ltd.: Strategic Outlook
List of Figures
Figure 1 Global Stem Cell Technologies and Applications Market Segmentation
Figure 2 Global Stem Cell Technologies and Applications Market Forecast by Region: Market Attractiveness Index
Figure 3 Global Stem Cell Technologies and Applications Market by Type: Market Attractiveness Index
Figure 4 Global Stem Cell Technologies and Applications Market by Cell Source: Market Attractiveness Index
Figure 5 Global Stem Cell Technologies and Applications Market by Product: Market Attractiveness Index
Figure 6 Global Stem Cell Technologies and Applications Market by Technology: Market Attractiveness Index
Figure 7 Global Stem Cell Technologies and Applications Market by Application: Market Attractiveness Index
Figure 8 Global Stem Cell Technologies and Applications Market: Market Dynamics
Figure 9 Global COVID Impact Analysis: Stem Cell Technologies and Applications Market Recovery Scenarios 2022-2032 (US$ Mn, CAGR (%))
Figure 10 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “V” Shaped Recovery
Figure 11 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “U” Shaped Recovery
Figure 12 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “W” Shaped Recovery
Figure 13 Global Stem Cell Technologies and Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)): “L” Shaped Recovery
Figure 14 Global Stem Cell Technologies and Applications Market: Porter’s Five Forces Analysis
Figure 15 Global Stem Cell Technologies and Applications Market: PESTLE Analysis
Figure 16 Global Stem Cell Technologies and Applications Market Forecast by Type 2022-2032 (Revenue, CAGR%)
Figure 17 Global Stem Cell Technologies and Applications Market Share Forecast by Type, 2022, 2032 (%)
Figure 18 Global Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 19 Global Allogeneic Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn)
Figure 20 Global Allogeneic Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn)
Figure 21 Global Autologous Stem Cell Therapy Market Forecast, 2022-2032 (US$ Mn)
Figure 22 Global Autologous Stem Cell Therapy Market by Region, 2022-2032 (US$ Mn)
Figure 23 Global Stem Cell Technologies and Applications Market Forecast by Cell Source 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 24 Global Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022, 2032 (%)
Figure 25 Global Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 26 Global Adipose tissue-derived MSCs Market Forecast, 2022-2032 (US$ Mn)
Figure 27 Global Adipose tissue-derived MSCs Market by Region, 2022-2032 (US$ Mn)
Figure 28 Global Bone marrow-derived MSCs Market Forecast, 2022-2032 (US$ Mn)
Figure 29 Global Bone marrow-derived MSCs Market by Region, 2022-2032 (US$ Mn)
Figure 30 Global Placental/umbilical cord-derived MSCs Market Forecast, 2022-2032 (US$ Mn)
Figure 31 Global Placental/umbilical cord-derived MSCs Market by Region, 2022-2032 (US$ Mn)
Figure 32 Global Stem Cell Technologies and Applications Market Forecast by Product 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 33 Global Stem Cell Technologies and Applications Market Share Forecast by Product, 2022, 2032 (%)
Figure 34 Global Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 35 Global Adult Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 36 Global Adult Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 37 Global Human Embryonic Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 38 Global Human Embryonic Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 39 Global Induced Pluripotent Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 40 Global Induced Pluripotent Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 41 Global Very Small Embryonic Like Stem Cells Market Forecast, 2022-2032 (US$ Mn)
Figure 42 Global Very Small Embryonic Like Stem Cells Market by Region, 2022-2032 (US$ Mn)
Figure 43 Global Stem Cell Technologies and Applications Market Forecast by Technology 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 44 Global Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022, 2032 (%)
Figure 45 Global Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 46 Global Cell Acquisition Market Forecast, 2022-2032 (US$ Mn)
Figure 47 Global Cell Acquisition Market by Region, 2022-2032 (US$ Mn)
Figure 48 Global Cell Production Market Forecast, 2022-2032 (US$ Mn)
Figure 49 Global Cell Production Market by Region, 2022-2032 (US$ Mn)
Figure 50 Global Cryopreservation Market Forecast, 2022-2032 (US$ Mn)
Figure 51 Global Cryopreservation Market by Region, 2022-2032 (US$ Mn)
Figure 52 Global Expansion & Sub-Culture Market Forecast, 2022-2032 (US$ Mn)
Figure 53 Global Expansion & Sub-Culture Market by Region, 2022-2032 (US$ Mn)
Figure 54 Global Other Technology Market Forecast, 2022-2032 (US$ Mn)
Figure 55 Global Other Technology Market by Region, 2022-2032 (US$ Mn)
Figure 56 Global Stem Cell Technologies and Applications Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR (%))
Figure 57 Global Stem Cell Technologies and Applications Market Share Forecast by Application, 2022, 2032 (%)
Figure 58 Global Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 59 Global Cancer Market Forecast, 2022-2032 (US$ Mn)
Figure 60 Global Cancer Market by Region, 2022-2032 (US$ Mn)
Figure 61 Global Cardiovascular Diseases Market Forecast, 2022-2032 (US$ Mn)
Figure 62 Global Cardiovascular Diseases Market by Region, 2022-2032 (US$ Mn)
Figure 63 Global Neurological Disorders Market Forecast, 2022-2032 (US$ Mn)
Figure 64 Global Neurological Disorders Market by Region, 2022-2032 (US$ Mn)
Figure 65 Global Inflammatory & Autoimmune Diseases Market Forecast, 2022-2032 (US$ Mn)
Figure 66 Global Inflammatory & Autoimmune Diseases Market by Region, 2022-2032 (US$ Mn)
Figure 67 Global Musculoskeletal Disorders Market Forecast, 2022-2032 (US$ Mn)
Figure 68 Global Musculoskeletal Disorders Market by Region, 2022-2032 (US$ Mn)
Figure 69 Global Other Applications Market Forecast, 2022-2032 (US$ Mn)
Figure 70 Global Other Applications Market by Region, 2022-2032 (US$ Mn)
Figure 71 Global Stem Cell Technologies and Applications Market Forecast by Region 2022-2032: Market Attractiveness Index
Figure 72 Global Stem Cell Technologies and Applications Market Share Forecast by Application, 2022, 2032 (%)
Figure 73 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn)
Figure 74 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 75 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 76 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 77 Global Stem Cell Technologies & Applications Market Forecast, 2022-2032 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 78 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%))
Figure 79 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 80 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 81 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 82 Global Stem Cell Technologies & Applications Market by Region, 2022-2032 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 83 North America Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 84 North America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 85 North America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 86 North America Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 87 North America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 88 North America Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 89 North America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 90 North America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 91 North America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 92 North America Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 93 North America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 94 North America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 95 North America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 96 North America Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 97 US Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 98 Canada Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 99 Europe Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 100 Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 101 Europe Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 102 Europe Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 103 Europe Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 104 Europe Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 105 Europe Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 106 Europe Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 107 Europe Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 108 Europe Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 109 Europe Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 110 Europe Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 111 Europe Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 112 Europe Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 113 Germany Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 114 UK Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 115 France Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 116 Italy Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 117 Spain Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 118 Rest of Europe Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 119 Asia-Pacific Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 120 Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 121 Asia-Pacific Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 122 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 123 Asia-Pacific Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 124 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 125 Asia-Pacific Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 126 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 127 Asia-Pacific Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 128 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 129 Asia-Pacific Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 130 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 131 Asia-Pacific Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 132 Asia-Pacific Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 133 Japan Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 134 China Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 135 India Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 136 South Korea Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 137 Australia Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 138 Rest of Asia-Pacific Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 139 Latin America Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 140 Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 141 Latin America Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 142 Latin America Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 143 Latin America Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 144 Latin America Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 145 Latin America Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 146 Latin America Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 147 Latin America Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 148 Latin America Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 149 Latin America Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 150 Latin America Stem Cell Technologies and Applications Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 151 Latin America Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 152 Latin America Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 153 Brazil Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 154 Mexico Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 155 Rest of Latin America Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 156 Middle East & Africa Stem Cell Technologies and Applications Market by Country: Market Attractiveness Index
Figure 157 Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 158 Middle East & Africa Stem Cell Technologies & Applications Market by Country, 2022-2032 (US$ Mn)
Figure 159 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Country, 2022 & 2032 (%)
Figure 160 Middle East & Africa Stem Cell Technologies & Applications Market by Type, 2022-2032 (US$ Mn)
Figure 161 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Type, 2022 & 2032 (%)
Figure 162 Middle East & Africa Stem Cell Technologies & Applications Market by Cell Source, 2022-2032 (US$ Mn)
Figure 163 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Cell Source, 2022 & 2032 (%)
Figure 164 Middle East & Africa Stem Cell Technologies & Applications Market by Product, 2022-2032 (US$ Mn)
Figure 165 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Product, 2022 & 2032 (%)
Figure 166 Middle East & Africa Stem Cell Technologies & Applications Market by Technology, 2022-2032 (US$ Mn)
Figure 167 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 168 Middle East & Africa Stem Cell Technologies & Applications Market by Application, 2022-2032 (US$ Mn)
Figure 169 Middle East & Africa Stem Cell Technologies and Applications Market Share Forecast by Application, 2022 & 2032 (%)
Figure 170 UAE Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 171 South Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 172 Turkey Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 173 Rest of Middle East & Africa Stem Cell Technologies & Applications Market by Value, 2022-2032 (US$ Mn)
Figure 174 Global Stem Cell Technologies and Applications Market: Company Share Analysis, 2021
Figure 175 Athersys, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 176 Athersys, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 177 Athersys, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 178 Athersys, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 179 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 180 Bristol-Myers Squibb Company: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 181 Bristol-Myers Squibb Company: R&D, 2017-2021 (US$ million, AGR (%))
Figure 182 Bristol-Myers Squibb Company: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 183 Cellular Biomedicine Group, Inc. : Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 184 Cellular Biomedicine Group, Inc. : Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 185 Cellular Biomedicine Group, Inc. : R&D, 2017-2021 (US$ million, AGR (%))
Figure 186 Cellular Biomedicine Group, Inc. : EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 187 Cynata Therapeutics Limited: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 188 Cynata Therapeutics Limited: R&D, 2017-2021 (US$ million, AGR (%))
Figure 189 Cynata Therapeutics Limited: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 190 Plus Therapeutics, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 191 Plus Therapeutics, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 192 Plus Therapeutics, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 193 Plus Therapeutics, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 194 BioRestorative Therapies, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 195 BioRestorative Therapies, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 196 BioRestorative Therapies, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 197 BioRestorative Therapies, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 198 Pluristem Therapeutics Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 199 Pluristem Therapeutics Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 200 Pluristem Therapeutics Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 201 Pluristem Therapeutics Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 202 Sangamo Therapeutics, Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 203 Sangamo Therapeutics, Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 204 Sangamo Therapeutics, Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 205 Sangamo Therapeutics, Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 206 StemCell Technologies Inc.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 207 StemCell Technologies Inc.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 208 StemCell Technologies Inc.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 209 StemCell Technologies Inc.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 210 Vericel Corporation: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 211 Vericel Corporation: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 212 Vericel Corporation: R&D, 2017-2021 (US$ million, AGR (%))
Figure 213 Vericel Corporation: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 214 BrainStorm Cell Limited. : R&D, 2017-2021 (US$ million, AGR (%))
Figure 215 BrainStorm Cell Limited. : EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 216 Gamida Cell Ltd.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 217 Gamida Cell Ltd.: EBITDA, 2017-2021 (US$ million, AGR (%))
Figure 218 Kangstem Biotech Co., Ltd.: Net Revenue, 2017-2021 (US$ million, AGR (%))
Figure 219 Kangstem Biotech Co., Ltd.: Gross Profit, 2017-2021 (US$ million, AGR (%))
Figure 220 Kangstem Biotech Co., Ltd.: R&D, 2017-2021 (US$ million, AGR (%))
Figure 221 Kangstem Biotech Co., Ltd.: EBITDA, 2017-2021 (US$ million, AGR (%))
List of Companies Profiled in the report
Athersys, Inc.
Biorestorative Therapies, Inc.
BrainStorm Cell Limited
Cellaïon SA
Cellular Biomedicine Group, Inc.
Cynata Therapeutics Limited
Gamida Cell Ltd.
Kangstem Biotech Co., Ltd.
Mesoblast Limited
Pluristem Therapeutics Inc.
Plus Therapeutics, Inc.
Sangamo Therapeutics, Inc.
StemCell Technologies Inc.
Vericel Corporation
ViaCyte, Inc.
List of Other Companies Mentioned in the report
ANGUS Chemical Company
Axol Biosciences Ltd.
BD Biosciences
Beckman Coulter Inc
Bio-Techne Corporation
Brainstorm Cell Limited.
CellGenix GmbH
Cellular Biomedicine Group, Inc.
Corning Incorporated
Creative Biolabs, Inc.
Cynata Therapeutics Limited
Cytiva
Danaher Corporation
Eppendorf AG
FUJIFILM Wako Pure Chemical Corporation
FyoniBio GmbH
Gamida Cell
HiMedia Laboratories
Kangstem Biotech
Life Technologies (India) Pvt Ltd.
Miltenyi Biotec
MP BIOMEDICALS
Pluristem Therapeutics Inc.
Plus Therapeutics, Inc.
R&D Systems, Inc.
REPROCELL Inc.
RoosterBio, Inc.
Sartorius AG
ScienCell Research Laboratories
StemCell Technologies Inc.
Takara Bio USA, Inc.
Titan Biotech Ltd.
Vericel Corporation
Viacyte, Inc.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
